Sterling Drug

Sterling Drug Sterling Drug was a major American pharmaceutical company that played a significant role in the development and marketing of various medicines. The company was founded in 1920 and operated for over seven decades, producing a range of products that treated various health conditions. During its operational years, Sterling Drug was involved in research and development, manufacturing, and distribution of pharmaceuticals, collaborating with other organizations such as Merck & Co. and Pfizer. Sterling Drug's products were sold globally, with a presence in countries like United States, Canada, and Europe.

History

Sterling Drug was founded in 1920 by Montgomery Ward, an American retailer, as a mail-order pharmacy. Initially, the company focused on producing and distributing generic and proprietary medicines. In the 1940s, Sterling Drug began to expand its operations, establishing a research and development division and introducing new products, such as aureomycin, an antibiotic developed in collaboration with Lederle Laboratories. The company continued to grow through acquisitions, including the purchase of Winthrop-Stevens, a pharmaceutical company founded by Alexander Winthrop.

Products and operations

Sterling Drug's product portfolio included a range of pharmaceuticals, such as antibiotics, antivirals, and cardiovascular drugs. One of its most notable products was Ritalin, a medication used to treat attention deficit hyperactivity disorder (ADHD)]}, developed in collaboration with Ciba Pharmaceuticals. The company also produced Magan B6, a vitamin supplement, and Ster-Zac, an antibacterial soap. Sterling Drug operated manufacturing facilities in the United States, Canada, and Europe, and had a significant presence in the global pharmaceutical market.

Corporate affairs

Sterling Drug was a publicly traded company, listed on the New York Stock Exchange (NYSE). The company was led by several notable executives, including Paul R. Dawson, who served as president and CEO from 1962 to 1977. Sterling Drug was also involved in various philanthropic efforts, supporting organizations such as the American Heart Association and the National Institutes of Health (NIH). In 1993, the company was acquired by American Home Products (AHP), which later merged with Wyeth and was eventually acquired by Pfizer.

Legacy and impact

Sterling Drug's legacy in the pharmaceutical industry is significant, with many of its products continuing to be used today. The company's commitment to research and development led to the introduction of innovative treatments for various health conditions. Sterling Drug's impact on the industry can be seen in its contributions to the development of pharmaceutical manufacturing and regulatory affairs. The company's history and operations serve as an example of the evolution of the pharmaceutical industry in the 20th century, with interactions between companies like Merck & Co. and Pfizer, and organizations like National Institutes of Health (NIH).

Category:Defunct pharmaceutical companies of the United States